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Abstract
The engineering of artificial tissues for restoration or replacement of organ function holds
the potential to alter the landscape of medical therapeutics. In many tissue engineering
approaches, cells seeded within 3D porous structures are expected to remodel into tissue-
like structures. Despite significant progress, difficulties in lack of control over tissue
architecture as well as vascularization continue to limit the efficacy of engineered
constructs. This thesis describes work aimed at tackling these two problems. First, two
techniques for generating size- and shape-controlled cell-laden hydrogels are described in
the context of potential modular assembly for conferring greater control over the
geometry of homotypic and heterotypic cell arrangements within engineered tissues.
Then, a method for producing cell-loaded microfluidic agarose hydrogels for tissue
engineering is described.
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Chapter 1
Introduction
Despite the impressive ability of many tissues within the human body to regenerate in
response to injury, entire classes of critical tissues such as cartilage, central nervous
system, and cardiac muscle are wholly incapable of regeneration. The impairment of
function accompanying common pathologies involving trauma or ischemia can be either
complete, often resulting in death, or partial, resulting in varying degrees of
unrecoverable functionality. One option for restoration of particularly vital functions is
partial or whole organ transplantation. However, due to the limited availability of
donors, only a fraction of those who could benefit from tissue transplantations actually
receive them. One potential approach for remedying the shortage of transplantable
organs is to artificially engineer tissues. Tissue engineering was first defined by Langer
and Vacanti as, "an interdisciplinary field that applies the principles of engineering and
life sciences to develop biological substitutes, typically composed of biological and
synthetic components that restore, maintain, or improve tissue function."1 Built on the
premise that functional tissues will arise from cells seeded in appropriately configured
scaffolds, tissue engineering techniques have been successfully applied to generate many
types of tissues; yet, numerous challenges persist. The work described here offers
potential workarounds to two of the most important of these challenges: nutrient/waste
exchange, and the inability to control the complex three-dimensional (3D) construction
and organization of cells within engineered tissues.
1.1 3D Scaffolds for Tissue Engineering
The traditional strategy for engineering 3D tissue has been to cultivate cells seeded
within porous biodegradable scaffolds made from either natural 2 or synthetic3 materials.
The purpose of such scaffolds is to serve as an environment within which nutrient and
oxygen transport as well as mechanical support1 are apposite for cell growth and
proliferation. In this approach, the scaffolds gradually degrade and become replaced by
extracellular matrix (ECM) molecules deposited by cells, eventually leading to
remodeling of the entire cell population into a macroscale tissue slab in the shape of the
scaffold. Porous scaffolds are currently generated through a variety of processes such as
solvent casting, particulate leaching2, freeze-drying 3, gas foaming4, and liquid-liquid
phase separation. Processing conditions facilitate control over pore size, geometry, and
interconnectivity.
Emerging techniques such as 3D printing, microsyringe deposition, and tissue spin
casting confer more precise control over microscale scaffold shape and architecture. 3D
printing in which a bed of powder is printed with a binder solution is typically used to
generate ceramic 5 scaffolds in orthopedic tissue engineering applications. Similarly,
microsyringe deposition relies on the same principle to generate poly(lactic-co-glycolic
acid) (PLGA) scaffolds6 for applications that require softer, more elastic materials.
Many variations of these approaches are available and have been the subject of
comprehensivereviews7-9comprehensive reviews
More porous scaffolds have been produced through the weaving of polymer nanofibers of
a few hundred nanometers in diameter. Techniques for fabricating these nanofibers such
as electrospinning, melt-blowing, phase separation, self-assembly, and template synthesis
have been applied to both natural and synthetic biomaterials1 °. For example
electrospinning in which a stream of discharged solvent threads via evaporation has been
shown to be compatible with both naturally-derived materials such as collagen, and
synthetic materials such as polycaprolactone (PCL) and poly(L-lactic acid) (PLLA), to
generate scaffolds in orthopedic'1 , cartilage 12, and cardiac tissue engineering 13
applications.
1.2 Strategies for Controlling Cell Remodeling
In traditional tissue engineering approaches, cells are induced to migrate within porous
scaffolds upon seeding. This process is often slow (and sometimes incomplete) and,
within larger scaffolds, may result in highly non-uniform cell distributions. Once cells
migrate to desired regions they can remodel the surrounding environment and associate to
generate functional tissues. A number of strategies have been implemented to induce
remodeling of these cell populations into more desirable 3D architectures. Growth
factors, chemoattractors, chemorepellents and other chemical factors have been used in
soluble format or directly fimunctionalized (in materials such as PLGA 14 and poly(ethylene
glycol) (PEG)15) to the scaffold material. For example, it has been shown that neural and
astrocyte stem cell differentiation can be modulated using hydrogel functionalized with
IKVAV oligopeptides (a cell-adhesive laminin-derived sequence) 16. Vascular endothelial
growth factor (VEGF) has also been shown to improve vascularization of engineered
bone in both in vitro4 and in vivo1 7 models. Additionally, functionalized molecules have
been patterned to guide cell growth and tissue remodeling. In a recent study, 3D
channels of GRGDS oligopeptides (a fibronectin peptide fragment known to be cell-
adhesive) were patterned into agarose matrices using a focused laser and verified to direct
axon extension .18  Alternatively, external stimuli such as the application of pulsatile
electric fields have been shown to improve functionality in cardiac myocyte orientation
and remodeling5 . Similarly, cultured smooth muscle cells loaded by cyclical mechanical
strain were found to upregulate elastin and collagen (standard ECM molecules) gene
expression while exhibiting increased organization in comparison to cells cultured on
19static substrates 19
Micro- and nano-textured substrates have been shown to significantly influence cell
adhesion, gene expression 20-22 and migration 23. These features can be incorporated
within tissue engineering scaffolds to provide physical environmental cues to cells. For
example, textured surfaces have been shown to improve osteoblast adhesions in a number
of orthopedic replacement/augmentation applications 24 . Although the exact mechanism
is not clear, it is believed that improved adhesion is caused by increased surface area.
Nanotextures with features less than 100 nm may be produced by a number of techniques
such as chemical etching in metals2 5, the embedding of carbon nanofibers in composite
materials 26, and the embedding of constituent nanoparticles in materials ranging from
metals to ceramics to composites 27-30 . These approaches to improving cell remodeling
for tissue engineering have been extensively reviewed in the literature 24
1.3 Current Challenges and Obstacles
Although tissue engineering approaches described above have been successfully applied
to the engineering of a variety of simple tissues such as skin and bone, more complex
structures with higher cell densities, greater metabolic requirements, and intricate 3D
architectures have been more difficult to engineer. Therefore it is believed that
alternatives to the traditional 'seed-in-a-scaffold' approach are worth exploring. Two of
the important immediate tissue engineering challenges are: 1) to enable nutrient and
waste exchange in macroscale tissue constructs3 1' 32 and, 2) to overcome the lack of
control of microscale 3D cell architectures in tissues in which proper function requires
the formation of complex homotypic and heterotypic structures.
A common strategy for enhancing nutrient/waste exchange is perfusion of cell-laden
macroporous scaffolds; however, this approach is suitable only for in vitro
experimentation. Alternatively, vascularization of tissue engineered constructs through
growth-factor induced angiogenesis 33 35 has produced promising results; yet, it is unclear
that such an approach is amenable for the production of stable blood vessels or larger
vasculature. Recently, tissue engineered constructs have been fabricated with soft
lithography to produce synthetic vasculature for enabling nutrient/waste exchange 36,37
however, the cells were coated within the channels as opposed to being embedded within
the device material itself. Furthermore, while strategies for recapitulating function and
complex 3D architecture in tissue engineered constructs by following the 'soluble factor'
and 'external stimuli' strategies described in Section 1.2 have afforded important
successes, most techniques have failed to produce fully or partial-but-substantially
functional tissue. Therefore, the goal of the work presented in this thesis is to address the
challenges of nutrient/waste exchange and complex 3D architecture.
Chapter 2
Background and Motivation
Traditional tissue engineering in which cells are seeded within scaffolds is limited by
difficulties in producing large, vascularized, complex tissues. Strategies such as
tissue/organ printing of cells and materials have been explored as a means of generating
complexity38' 39. While tissue printing is promising for reproducing native three-
dimensional (3D) architecture involving multiple cell types, the scalability of such
approaches is unclear given that sequential layer-by-layer deposition also implies
sequential exposure to potentially toxic gelling conditions. Alternatively, highly porous
cell-seeded tissue engineering structures have been perfused as a means to maintain cell
viability. This is a clever approach but it is unclear how such constructs would be
connected to the blood supply in vivo as there is very little control over the specific
porous architectures. Therefore, other strategies for conferring more precise control over
the 3D architecture of engineered tissues as well as for enabling nutrient/waste exchange
may be worth exploring. This thesis presents three standalone works developing three
techniques, each described within separate chapters (Chapters 3-5). Chapters 3 and 4
document two techniques for fabricating the same types of shape- and size-controlled
microstructures; these structures are considered in the context of a single strategy for
generating complexity. Chapter 5 describes a technique for fabricating a different type of
structure, for use in an unrelated strategy for enabling nutrient/waste exchange.
This chapter will orient the reader by 1) describing previous work in which hydrogel
materials (the materials used here in all three works) were used for cell encapsulation, 2)
reviewing the existing techniques for generating microscale features in cell encapsulated
hydrogels, 3) providing an overview of the soft lithography technology employed by all
three techniques described in the thesis, and 4) defining the basic design criteria for the
structures produced to be compatible with tissue engineering. To reiterate, the three
techniques presented in this thesis are considered in the context of two disparate
strategies for addressing two separate problems in tissue engineering. For clarity, we will
now discuss background issues of common relevance to all three techniques (Section 2.1,
2.2). We will then discuss the two strategies separately and in turn (Section 2.3, 2.4).
2.1 Hydrogels for Cell Encapsulation
Hydrogels are synthetic or naturally-derived hydrophilic polymer networks that swell
greatly in water. They are commonly found in household items such as contact lenses
and disposable diapers40,41. Among numerous other applications, hydrogels have been
used for cell encapsulation since their mechanical properties resemble that of native
tissues while intrinsically exhibiting high permeability to oxygen, nutrients, and other
water-soluble metabolites 42' 43. In addition, hydrogels display mechanical and chemical
properties that may be engineered (addition of functional groups, modulation of
degradation rates) to exhibit other desirable characteristics. Due to this customizability,
hydrogels have been widely used in tissue engineering and drug delivery applications 44' 45.
In traditional tissue engineering, cells are seeded upon the surface of porous scaffolds
(with pores sufficiently large to enable cell migration) and induced to migrate and
populate the inner regions. In many cases cells do not evenly seed within the scaffold
because of the large distances they must migrate in order to populate the scaffolds.
Attempts have been made to homogenize cell seeding distribution through, for example,
the application of centrifigual force to surface-seeded scaffolds46 or the continuous
perfusion of scaffolds with cell suspended solutions47-49. These techniques require
cumbersome equipment and have not, to our knowledge, been demonstrated for
microscale scaffold constructs. In contrast, the techniques described here use the
encapsulation of cells within hydrogel materialsa. The advantage of cell encapsulation to
cell seeding in porous scaffolds for tissue engineering is the homogeneity of cell
distribution that may be achieved. In cell encapsulation applications, cells are embedded
within hydrogels by suspending the cell in a liquid hydrogel precursor, followed by
crosslinking of the polymer network. In this way, uniformly-distributed hydrogel-
encapsulated cells are required to migrate much shorter distances during the subsequent
remodeling of cells into tissue.
To encapsulate cells, they are mixed with the hydrogel precursors and subsequently
c:rosslinked. The crosslinking reaction may be controlled by a variety of non-cytotoxic
stimulating factors such as temperature, pH or the addition of ions. Furthermore,
hydrogels can be photopolymerized in the presence of photoinitiators via exposure to
ultraviolet (UV) light50 . Both biologically-derived hydrogels (e.g. fibrin 51, hyaluronic
a Note that hydrogels are also porous, though at nanoscales, so that while liquid diffusion is unhindered cell
(A8 gm diameter for mammalian cells) migration is initially (prior to matrix degradation) unlikely.
acid (HA)52 , agarose53) and synthetic hydrogels (e.g. poly(ethylene glycol) (PEG)54' 55)
have been used to encapsulate cells. For example, photopolymerized PEG diacrylate
hydrogels were explored for the transplantation of islets of Langerhans for the
development of a bioartificial pancreas56-58. Similarly, photopolymerized HA hydrogels
have been investigated as potential implantable/injectable cell delivery vehicles for
cartilage regeneration 59 . Alternatively, alginate polymers that crosslink with the addition
of calcium ions have been studied for the encapsulation of islet cells 60' 6 1
2.2 Soft Lithography
Soft lithography is a suite of techniques inspired by the semiconductor industry in which
'soft' materials are used to replicate micro- and nano-scale patterns62 ; it provides one
avenue for creating microfeatured hydrogel materials. These patterns are often generated
through photolithography (Figure 2.1A, 2.1B, 2.1C), in which a planar mask enables
selective exposure of a thin film of photoresist upon a silicon wafer to UV. Exposed
regions of photoresist then crosslink, transferring the features of the mask onto the thin
film. Reusable patterned silicon masters63,64 produced through photolithography have
been utilized to generate relief structures in materials such as polyimides, polyurethanes,
and most commonly, poly(dimethylsiloxane) (PDMS). The reusability of the silicon
masters streamlines the fabrication process and greatly minimizes the need for costly
photolithographic equipment and cumbersome clean room facilities. However, a
disadvantage of soft lithography is that the features created are inherently planar. In soft
Photolithography
3D View Side View
Soft Lithography
3D View Side View
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Figure 2.1: Schematic comparison of photolithography (left) and soft lithography
(right). Photolithography uses, (a) a patterned mask to (b) selectively expose and
crosslink regions of polymer, (c) resulting in patterned silicon wafers. Soft lithography
utilizes these patterned wafers to (d) mold liquid prepolymer which can be (e) cured or
polymerized to produce negative copies of the patterned silicon wafer in relief
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lithography, cast molding (Figure 2.1D, 2.1E, 2.1F), is typically employed to generate
relief structures in the elastomeric material.
Although many variations exist, the fundamental process is as follows: 1) a prepolymer
solution is poured on top of a patterned silicon master, 2) a curing or polymerization-
inducing agent is mixed into the prepolymer solution either before or after the pouring, 3)
the material is cured or polymerized, 4) the solidified material with an imprint of the
features of the silicon master in relief is peeled away from the master; the master can now
be reused. A wide range of variations on the fundamental dogma of soft lithography such
as replica molding, microtransfer molding, and microcontact printing have been
developed 62 . Among many applications, elastomeric materials have been used to
microcontact print surfaces for cell patterning 64, form microfluidic channels for the study
of chemotaxis 65, and micromold arrays of microwells for high-throughput cell studies 66.
The production of both cell-loaded hydrogel microstructures and channel-featured
constructs described here are based on soft lithography technology.
2.3 Bottom-Up Tissue Engineering: Overview and Background
Chapters 3 and 4 describe methods developed in this work for producing microstructures
that may be used to generate complexity in a 'bottom-up' approach in which, like Lego
blocks, assembly would begin from smaller microscale components in which cells are
embedded. These shape-fitting microscale components containing different cell types
may then be built up into larger meso- or macroscale constructs in a controlled manner.
This two-step process can therefore be broken up into the fabrication of these
microstructures and the achievement of self-assembly. The work described in Chapters 3
and 4 is aimed at developing the fabrication techniques; self-assembly is left for future
work although further rationale and background data regarding potential approaches are
provided in the concluding chapter.
Previous techniques for encapsulating cells within microscale hydrogels were motivated
by a desire to improve cell viability in the center of encapsulation constructs due to lack
of appropriate levels of oxygen and nutrient diffusion through macroscale constructs 56' 67
As such, spherical microcapsules with high surface area to volume ratios and coated
annuli of cells immobilized within polymers were generated to overcome these transport
difficulties59. To date most synthetic cell-laden microstructures have been limited to
spheres because of the incompatibility of current technologies, based on
emulsification 68,69 or shear-induced droplet formation from syringes 53 , to generate
microscale structures of other shapes. While these techniques have been shown to be
capable of forming spherical cell-laden microgels of controlled sizes, the lack of ability to
generate non-spherical shape-fitting modular components circumscribes their efficacy for
bottom-up tissue engineering.
Recently, photolithography 70-72 and soft lithography73 (discussed previously in Section
2.2) were used to encapsulate live cells within small units of polymeric hydrogels
anchored upon two-dimensional (2D) surfaces. These systems offer great potential for
diagnostic and cell screening applications 74. However, the specific techniques are
incompatible with th formation of free components63,64. Nonetheless the fabricationincompatible with the formation of free components '. Nonetheless the fabrication
techniques involved in the generation of free cell-laden microstructures were inspired by
the general approaches of these previous works.
Micromolding was used in the work documented in Chapters 3 and 4 to produce shape-
and size-controlled cell-laden microstructures. Micromolding is a straightforward
derivative of soft lithography in which microstructures are molded from elastomeric
materials generated by the previously described cast molding process. In short, the liquid
prepolymer solution is sandwiched between a patterned elastomeric surface and a flat
surface and induced to cure or polymerize so as solidify in the shape of the mold. In
principle, micromolding is capable of producing free hydrogel microstructures of
controlled size and shape for tissue engineering.
Various micromold-able materials may be polymerized in different ways. Therefore, to
enable the use of a wide range of hydrogel materials for bottom-up tissue engineering it is
desirable to formulate alternative methods to fabricate microstructures from various cell
encapsulation compatible hydrogels. Chapters 3 and 4 of this thesis describe the
production of two classes of cell-loaded hydrogel microstructures for bottom-up tissue
engineering: UV photopolymerizable, and chemical crosslinkable. Photopolymerizable
polymers were previously discussed in Section 2.1; the third chapter is devoted to work
demonstrating the photopolymerization approach with PEG diacrylate and
methylacrylated hyaluronic acid (MeHA) as model photopolymerizable cell
encapsulation materials. This work is straightforward in that the sandwiched material
will polymerize upon UV exposure.
This simple micromolding approach could not be applied to a wide variety of chemical or
pH-dependant crosslinking hydrogels such as alginate, chitosan and fibrinogen.
Previously 75, alginate microfluidic devices were fabricated by pouring the hydrogel
precursor over a mold followed by the immersion of the setup in a bath containing the
gelling agent. However, this procedure cannot be easily adapted to produce individual
microparticles. The essential challenge to the micromolding of chemical or pH-
dependant crosslinking hydrogels is their rapid gelling, which occurs immediately upon
contact with the gelling agent. Controlling the shape and size of microparticles and
microstructures made from these hydrogels has not been possible by using previously
reported techniques. In the fourth chapter of this work, the controlled release of a gelling
agent from a soft lithographically generated hydrogel mold is used overcome this
limitation.
For self-assembly of cell-laden microstructures to be feasible for tissue engineering, the
fiollowing set of criteria were considered. First, the processing conditions had to be
sufficiently mild so as to maintain an acceptable percent viability of encapsulated cells
(-80% initial viability is conventionally accepted 76). Different cell types were expected
to be more or less resilient to processing conditions; since the technique was not intended
to be organ-specific the identity of the cell type was not important and a convenient and
commonly used cell line could be used (the NIH-3T3 fibroblasts are extremely well-
characterized and commonly used as a conventional 'model' cell in tissue engineering 76).
Next, the technique had to allow for the production of various controlled shapes using
(possibly charged or charge-functionalizable) materials that could potentially fit together
(for examples, cubes or other hexahedrons) in a charge and shape complementary fashion.
At this early proof-of-concept stage a rigorous analysis of shape reproduction was not so
important but future characterization will be essential for application to bottom-up tissue
engineeringb. To be consistent with the size range of previous mesoscale self-assembly
methods 77, the microstructures needed to roughly be in the range of 50 - 1000 pm in each
dimension.
2.4 Cell-Laden Microfluidic Constructs: Overview and Background
Chapter 5 describes a method for fabricating synthetic microfluidic flow channels within
macroscale cell-loaded constructs as a means of enabling nutrient/waste exchange. These
channels could then be perfused to facilitate controlled diffusion-based maintenance of
cell viability.
In microfluidics, the controlled flow of fluids within microscale channels has be used to
78,79perform biological analyses and assays  . Microfluidic devices require minimal
reagent consumption, allow for the laminar flow of fluids, and may be used for high-
throughput analysis80 . Currently, microfluidic devices are most commonly fabricated
using soft lithography from poly(dimethyl siloxane) (PDMS) 81-84, a flexible silicone
rubber that is optically transparent and therefore amenable for analyte visualization.
Since PDMS is non-toxic, cells may be cultured on its surfaces or along the walls of its
mrnicrochannels. However, cells cannot be cultured within the PDMS bulk material. In
addition, materials such as poly(DL-lactic-co-glycolide) (PLGA) and poly(glycerol
b Please note that specific discussions on the types of shapes most conducive to self-assembly (i.e. number
of potential slip planes, symmetry) were considered outside of the scope of our work but are discussed to
some degree in the final chapter (which considers future self-assembly work).
sebacate) (PGS) as well as PDMS have been used to engineer microvasculature within
synthetic scaffolds 85. In these works 86-88, endothelial and hepatic cells were seeded
within complex microfluidic channel patterns as a potential method to generate blood
vessels and liver constructs for 3D tissue engineering. This approach is potentially
powerful for engineering vasculature, which is an important challenge in making 3D
constructs. While PGS and PLGA are biocompatible and biodegradable, potential
limitations of this approach include the difficulty of achieving uniform cell seeding, the
high volume of the scaffold material which must be degraded, and the 2D surface
microenvironment of the scaffolds. The alternative approach presented here aims to
overcome these limitations by utilizing hydrogel cell encapsulation technology. Recently,
the first hydrogels, calcium alginate75 and gelatin8 9, were used to fabricate microfluidic
devices. Also, it was demonstrated that cells could be seeded on the surface the
microchannels within these devices.
However, no previous work has shown the capacity to perfuse, using highly controlled
channels, cells encapsulated within the surrounding material. As such, primary
consideration in our work was given to cell maintenance within the perfused construct.
The mechanical properties of the material were considered only insofar as their
compatibility with the fabrication of sufficiently stiff and perfusable channels (with the
simplest channel patterns available and cross-sectional areas in the range of typical
arterioles or capillaries). As with the cell-loaded microstructures described above, the
processing conditions had to be sufficiently mild so as to maintain an acceptable percent
viability of encapsulated cells (-80% initial viability is conventionally accepted 76).
Again, cell type was not considered an important parameter and so a commonly used cell
line (AML-12 here) could be used. Since the criterion considered most important for this
first demonstration was that the material allow for nutrient/waste exchange, it was
necessary to verify the capacity of such a construct to maintain cell viability over time.
In summary, Chapters 3 and 4 will describe micromolding approaches for producing
shape- and size-controlled cell laden microstructures. To increase the number of
micromoldable cell encapsulation materials that may be used in bottom-up tissue
engineering, techniques for utilizing both photocrosslinkable (Chapter 3) and chemically
crosslinked (Chapter 4) hydrogels are developed. Chapter 5 will then describe the
fabrication of microfluidic cell-laden hydrogel constructs with a brief discussion of future
directions. Finally, the thesis will conclude with a chapter detailing future bottom-up
tissue engineering work and the specific ways by which shape- and size-controlled cell
laden microstructures could be self-assembled.
Chapter 3
UV Crosslinked Hydrogel Microstructures
This chapter discusses the fabrication and characterization of ultraviolet light (UV)
crosslinked cell-laden microstructures which could potentially be used in bottom-up
tissue engineering. Two model UV-crosslinkable materials, poly(ethylene glycol)
diacrylate (PEGDA) and hyaluronic acid methacrylate (MeHA) were used (reactions
illustrated in Figure 3.1). Briefly, NIH-3T3 fibroblast cells were suspended in a hydrogel
precursor solution containing photoinitiator, deposited onto hydrophilic
poly(dimethylsiloxane) (PDMS) patterns, crosslinked under UV radiation, and retrieved
upon hydration. Application of this technique yielded size- and shape-controlled
microstructures with generally homogeneous cell distributions at various cell densities.
Hyaluronic acid (HA) is a negatively charged natural component of the extracellular
matrix (ECM) known for its biodegradable and bioresistant properties90,91 as well as its
role in facilitating cellular functions such as adhesion, proliferation, and migration 92.
PEG is a synthetic, inert, non-biofouling material often used in templates for
immobilizing cells on two-dimensional (2D) surfaces 63,64 or within microfluidic
channels63. A large body of literature exists describing the addition of functional groups
to PEG to modulate characteristics such as charge and degradation rate72
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Figure 3.1: Photopolymerization of PEGDA and MeHA. PEGDA hydrogel networks
undergo polymerization at the carbon-carbon double bonds of the acrylate group
functionalized to the ends. Two primary radicals, generated by the photoinitiator when
exposed to UV light, propagate through the electron-rich acrylate groups. The
subsequently generated kinetic chains result in crosslinked PEG. Similarly, the
functionalized methacrylate groups of MeHA enable free radical polymerization in the
presence of photoinitiator.
The goal of this work was to provide a proof-of-principle that a photopolymerization
micromolding approach could be used to produce free shape- and size-controlled
microstructures. Previous work has thoroughly explored the properties and design
considerations of hydrogels 93. Rather than a rigorous and thorough analyses of biological
and mechanical properties, this work was focused on demonstrating the possibility of
producing free microstructures with acceptable viability (-80% viable), reproduction
fidelity (produced in the general shape of their molds), and structural integrity (could be
harvested in solution without dispersing into debris). The mechanical and biological
properties of PEGDA are more thoroughly characterized than MeHA in existing literature.
While cells were encapsulated in both PEGDA and MeHA systems, processing
parameters (using our model materials) like UV exposure length, prepolymer
concentration and photoinitiator concentration were only explored to increase cell
viabilities for MeHAc. Despite differences in biocompatibility the processing properties
were not expected, and were not found in this work, to differ substantially between the
two materials.
C An additional reason we focused more on MeHA is that the mechanical and cell viability characteristics in
PEG encapsulation systems have been thoroughly well-characterized in the past.
3.1 Materials and Methods
3.1.1 Cell Culture
All cells were manipulated under sterile tissue culture hoods and maintained in a 95%
air/5% CO2 humidified incubator at 370 C. NIH-3T3 mouse embryonic fibroblast cells
were maintained in Dulbecco's modified Eagle media (DMEM) supplemented with 10%
FBS. Confluent dishes of NIH-3T3 cells were passaged and fed every 3-4 days.
3.1.2 Prepolymer Solution
Two macromers were used: PEGDA and MeHA. The synthesis of MeHA was previously
reported95. In brief, the synthesis was performed by the addition of 1 wt% methacrylic
anhydride (Sigma) to a solution of 1 wt% HA (Lifecore, MW = 67 kDa) in deionized
water. The reaction was performed for 24 h on ice and maintained at a pH of 8-9 through
the addition of 5N NaOH. The macromer solution was then purified by dialysis (Pierce
Biotechnology, MW cutoff 7 kDa) for 48 h in deionized water and lyophilized for 3 days,
resulting in a final dry form which was frozen for storage. The prepolymer form of
MeHA was created by dissolving dry MeHA in PBS (Gibco) at 37°C for 24 h to facilitate
full dissolution. Immediately prior to UV photopolymerization, varying concentrations
of photoinitiator solution were added to the prepared prepolymer solution. The
photoinitiator solution used was 33 wt% 2-hydroxy-l-(4-(hydroxyethoxy)phenyl)-2-
methyl- 1-propanone (Irgacure 2959, CIBA Chemicals) in methanol.
To generate PEG hydrogels, a solution containing 10% (w/w) PEGDA (MW 575, Sigma)
in PBS (Gibco) was prepared prior to experiments in order to allow the PEGDA to
adequately dissolve into solution. Immediately preceding UV photopolymerization,
photoinitiator solution was added to the prepolymer solution at 1 wt%. The photoinitiator
solution used was also 33% (w/w) 2-hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-
propanone (Irgacure 2959, CIBA Chemicals) in methanol.
3.1.3 PDMS mold fabrication
PDMS molds of various shapes were fabricated by curing prepolymer (Sylgard 184,
Essex Chemical) on silicon masters patterned with SU-8 photoresist. The patterns on the
masters had protruding patterns (squares, circles, long rectangles) of various sizes
(ranging from 50 to 400 gm), which allowed for the formation of shaped wells in PDMS
replicas. PDMS molds were generated by pouring 1:10 curing agent to silicon elastomer
onto the master and curing for 2 h at 37°C. Finally, the PDMS molds were peeled from
the silicon masters, cut into small rectangular shapes, and placed over glass slides to
facilitate ease of manipulation. The use of glass slides allowed direct manipulation of the
slides, thereby minimizing the possibility of damaging the molds. Before use the molds
were rendered hydrophilic by plasma cleaning for 45 s on medium power (PDC-001,
Harrick Scientific). Untreated (hydrophobic) flat sections of PDMS were similarly
placed over glass slides and used as coverslides to reversibly seal the prepolymer solution
within individual volumes during the micromolding procedure.
3.1.4 Microstructure Polymerization
The micromolding procedure schematized in Figure 3.2 was used to fabricate
microstructures of controlled shapes and sizes. To suspend NIH-3T3 cells within the
prepolymer solution, the cells were first trypsinized with 0.23% trypsin and 0.13%
ethylenediaminetetraacetic acid (EDTA) in PBS (Gibco). The suspension was then
centrifuged at 1000 rpm for 2 min to produce a cell pellet. The pellet was resuspended in
controlled volumes of the prepolymer solution. This yielded differing concentrations of
cells in prepolymer solution (cell density values are reported as cells/ml of the
prepolymer). 20 - 25 tL cm 2 of this cell/polymer mixture was then pipetted onto freshly
plasma oxidized PDMS molds. The tip of the pipette was gently brushed on the mold
surface to remove any bubbles. A PDMS coverslide was then carefully applied on top of
the mold and gently rotated under slight finger pressure to ensure PDMS/PDMS contact.
The mold/polymer-solution/coverslide assembly was then exposed to -1 W cm -2 360-480
nm UV light for various durations. Finally, the coverslide was carefully removed and
PBS was immediately pipetted onto the coverslide surface upon which the
microstructures were adhered to hydrate the newly formed hydrogels.
3.1.5 Microstructure Harvesting
After photopolymerization, the coverslide was separated from the PDMS mold to retrieve
the microstructures. In this process, a fraction of the microstructures adhered within the
wells of the mold while the other fraction adhered to the PDMS coverslide. For
convenience, those microstructures which adhered to the PDMS coverslide upon removal
of the coverslide from the PDMS mold were then harvested while those which remained
adhered within the microwells were discarded. After hydrating the microstructures upon
the coverslide, a number of individual microstructures spontaneously detached from the
coverslide while a number remained adhered. A pipette tip was gently brushed over the
coverslide to mechanically detach the remaining microstructures. Reproduction fidelity
for (10% MeHA, 1% photoinitiator, 180 s UV exposure) 400 x 400 gm square
hexahedrons (these became slightly rectangular) was determined by dividing the length
of the short axis by that of the long axis (n = 6). Planar swelling was determined for
(10% MeHA, 1% photoinitiator, 180 s UV exposure) square hexahedrons molded within
400 gm x 400 gm x 50 im by dividing the top-down planar surface area by 400 x 400 gm
(n = 6).
3.1.6 Imaging and Analysis of Encapsulated Cells
Initial encapsulated cell viability was assessed by applying a live/dead (calcein AM and
ethidium homodimer) fluorescence assay to a model polymer system, consisting of cells
encapsulated in thin layers of HA hydrogel made by deposition of 20 il cell/prepolymer
mixture between a glass slide and a flat PDMS coverslide. After photopolymerization,
the PDMS coverslide was removed, leaving a thin layer of cell-loaded polymer adhered
to the glass slide. The thin layer was subsequently hydrated with 200 jl PBS solution
containing 2 pg/ml calcein AM and 4 jg/ml ethidium homodimer-1 (Molecular Probes)
and visualized under a fluorescent microscope (Zeiss, Axiovert 200). Initial cell viability
assessments were made using NIH-3T3 cells encapsulated within MeHA thin layer
hydrogels in which the macromer concentration, UV exposure duration, and
photoinitiator concentrations were varied.
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Figure 3.2: Process of cell encapsulation and microstructure formation. (A) Cells
are suspended in prepolymer solution and deposited onto a plasma-cleaned PDMS mold.
(B) A PDMS coverslide is placed on top, forming a reversible watertight seal. (C) Liquid
prepolymer is photopolymerized via exposure to UV light. (D) The PDMS coverslide is
lifted, (E) permitting removal of the microstructures which are then (F) hydrated and
harvested.
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Two recognized parameters of cell viability - intracellular esterase activity and plasma
membrane integrity - were tracked. Live cells fluoresced green, exhibiting intracellular
esterase activity that hydrolyzed the fluorogenic esterase substrate (calcein AM) to a
green fluorescent product; dead cells fluoresced red, their plasma membrane being
compromised and therefore permeable to the high-affinity, red fluorescent nucleic acid
stain (ethidium homodimer-1). Percent viability values were calculated by counting the
number of live (green) cells and the number of dead (red) cells in a representative 400tm
x 400pm square area magnified at 50X (or embedded within individual microstructures)
and dividing the number of live cells by the number of total cells (live plus dead).
Measurements were taken in triplicates, and error bars were based on standard deviation
values for n=3 unless otherwise indicated.
For confocal microscopy, cells were stained with Vybrant DiD (Molecular Probes) at
20il/ml in PBS, fixed with Fluoromount-G, and covered with a No. 1 thickness coverslip.
Confocal images were taken at 40x magnifications through a Rhodamine filter with a
maximum focal depth of 248 pm. CFSE and PKH26 staining were performed 96 at room
temperature prior to microscopy.
3.2 Results
3.2.1 Microstructure Fabrication
Using the micromolding approach schematized in Figure 3.2, cell-free MeHA and
PEGDA microstructures of various shapes at 10% macromer and 2% photoinitiator
concentrations exposed for 180 s to UV light were generated. Representative images of a
few of these cell-free square hexahedrons, cylinders, and strings are shown in Figure 3.3.
The planar swelling of 10% MeHA, 1% photoinitiator, 180 s UV exposed microstructures
produced from 400 x 400 ýtm square molds was 73% with a standard deviation of 22%.
The ratio of short to long axes of 10% MeHA, 1% photoinitiator, 180 s UV exposed
microstructures produced from 400 x 400 gm square molds was 0.94 with a standard
deviation of 0.05. This places it slightly over one standard deviation away from the value
of a perfect square (1).
Figure 3.3: Versatility of microstructure shapes. Microstructures of various shapes
can be micromolded: square hexahedrons (A, B), cylinders (C), and string-like
rectangular hexahedrons (D, stained with trypan blue to facilitate visualization) using
different prepolymer solutions: (A) MeHA and (B, C, D) PEGDA.
3.2.2 Characterization of Initial Cell Viability
Cell viability was tracked as a function of photoinitiator concentration, UV exposure
length, and macromer concentration in a thin-layer MeHA model (Figure 3.4). Viability
exhibited significant decreases with increasing UV exposure length for any given
photoinitiator and macromer concentrations (Figure 3.4). When other parameters were
held constant increasing either macromer concentration or photoinitiator concentration
individually also decreased cell viability.
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Figure 3.4: Characterization of initial cell viability. Varied parameters include
macromer (HA) concentrations, photoinitiator (Irg for Irgacure) concentrations, and UV
exposure durations. Control values (0 s) are provided for reference. Error bars indicate
standard deviation values for n = 3.
3.2.3 Cell Encapsulation within Microstructures
Facile retrieval is shown between Figure 3.5A/3.5C, in which the microstructures were
initially fabricated (and left residing as an array attached to the coverslide), and Figure
3.5B/3.5D, in which the microstructures were subsequently hydrated and suspended (now
at oblique angles). Upon being pushed with a micromanipulator, the dead (stained red)
cells at the periphery of the microstructures were found to be mobile while those
presumably embedded within the hydrogel material moved in registration with the outline
of the microstructures. The ability to vary cell density while maintaining viability >85%
is shown in Figure 3.6.
MeHA and PEGDA microstructures fabricated at 10 wt% macromer, 1% photoinitiator,
and UV exposed for 45 s yielded initial viability values >85% for both materials (Figure
3.7). The microstructures were qualitatively observed to exhibit more uniformity in a
top-down view (Figure 3.7A-D) and somewhat less uniformity throughout the depth
(Figure 3.7E). Time-course viability remained >85% for up to 4 days in MeHA
microstructures (Figure 3.8). In the day 4 fluorescent image (Figure 3.8), one
microstructure in the lower left corner appears to have substantially lower viability than
surrounding structures.
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Figure 3.5: Harvesting microstructures. Removal of the PDMS coverslide following
UV exposure yields (A) a uniform array of HA microstructures with cells encapsulated
within. Subsequent hydration (C) allows these microstructures to be dislodged and
suspended in solution. Viability stains (B, D) indicate >85% (n = 3) cell viability.
Figure 3.6: Variation in cell density. Cell density in microstructures can be controlled.
Variations shown range from (A,B) 5x107 cells/ml to (C,D) 20x107' cells/ml MeHA
prepolymer solution. Viability stains (B, D) show >85% (n = 3) viability. Light
micrographs (A,C) were taken at different phases and so the images look different. The
appearance of cells in A as outside of the microstructures is a function of the optical
phase used; the cells were determined to be embedded within the microstructures by
verifying the motion of cells in registration with the microstructures when jostled with a
micromanipulator. The focus was slightly adjusted between C and D to produce sharper
images so not all cells visible in C are visible in D.
Figure 3.7: Cell encapsulation, viability, and distribution. Cells were encapsulated in
(A) MeHA and (C) PEGDA microstructures and stained with viability markers (B, D). (E)
Confocal imaging shows some inhomogeneity in the lateral portions (rhodamine-stained)
throughout the depth of one MeHA microstructure.
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Figure 3.8: Cell viability over 4 days. These representative live/dead stained and
corresponding light microscope images of cell-loaded microstructures show the
maintenance of cell viability >85% (n = 9) for up to 4 days.
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3.3 Discussion
3.3.1 Microstructure Fabrication
In comparison to previous methods for producing microscale hydrogels (limited to
spheres), the advantage of a soft lithographic fabrication technique is that it can be used
to produce free microstructures of virtually any planar shape and fixed height as long as
the desired pattern can be fabricated in the PDMS molds. Figure 3.3 demonstrates this
ability to generate different shapes (square hexahedrons, cylinders, rectangular
hexahedrons) using different materials (MeHA, PEGDA).
It has previously been shown in quantitative characterizations that macromer
52concentration can significantly alter hydrogel properties such as swelling and elasticity 52
We did not replicate these analyses but did qualitatively observe this swelling property
(as well as assess it quantitatively for 10% MeHA) in our own experiments. We further
expected and observed that the mechanical robustness of the microstructures increased
with increasing macromer concentrations: mechanical stimulation of MeHA
microstructures of low macromer concentrations tended to fragment them into debris
while stimulation of microstructures of higher macromer concentrations had no apparent
effect. Since the material properties of hydrogels are well-characterized in the literature
we chose to focus more on a biocompatibility parameter-cell viability.
3.3.2 Characterization of Initial Cell Viability
It has previously been shown that increasing photoinitiator concentration, UV exposure
length, and macromer concentration negatively impacts the viability of cells encapsulated
within PEGDA and other photopolymerized hydrogels 52' 97' 98. This was found to be the
case in thin layers of photopolymerized MeHA (Figure 3.4). Based on these results,
parameters of 5% MeHA, 1% photoinitiator, and 60 s UV-exposure was determined, of
the parameters tested, to be most satisfactory for maintaining cell viability within thin
hydrogel films. This was in line with our expectation, based on past work 52, that lower
macromer concentrations, lower photoinitiator concentration, and shorter UV exposure
lengths would increase cell viability. Although even lower parameter values would likely
have further increased cell viability, it was observed that further lowering any of these
three parameters resulted in noticeable debris formation upon photopolymerization.
Though a thin-layer may not be a perfect model for the viability of cells loaded within
microstructures, it was useful for screening parameters.
3.3.3 Cell Encapsulation within Microstructures
A number of difficulties in realizing the ability to harvest free cell-laden MeHA
microstructures in solution (Figure 3.5) were encountered that were not experienced in
harvesting cell-free microstructures. Using PDMS molds in which the microwells
accounted for -25% of the planar area, the fabrication of microstructures was plagued by
formation of a thin film between the PDMS coverslide and the PDMS pattern upon
photopolymerization of the prepolymer/cell mixture. This film interfered with the
harvesting of individual microstructures as the particles were attached to the thin film.
This phenomenon transpired presumably as a result of cells (which did not fall into the
molds) being sandwiched between the coverslide and non-well areas of the pattern pieces,
thereby preventing complete sealing between the coverslide and pattern. It was
minimized by using PDMS patterns with smaller spacing (-70% of the planar area)
between the negative features such that the cells could more easily be displaced to the
microwells and decreased the likelihood that a cell would be sandwiched between the
coverslide and the non-well areas of the pattern pieces. In addition, the PDMS coverslip
was maintained in a hydrophobic state to maximize dewetting of the solution from the
surface and thus minimize the formation of thin films between microstructures. In the
future the problem may also potentially be overcome by utilizing microwell patterns with
hydrophobic surfaces and hydrophilic wells. An additional complication of generating
photopolymerized cell-loaded microstructures versus cell-free microstructures was the
added viscosity of prepolymer solution in which cells are suspended. This additional
viscosity is believed to be responsible for the difficulties encountered in making cell-
loaded microstructures smaller than 400 gm. Using PDMS molds with microwells that
were smaller than 400 gm (as low as 50 gm), it was found that gels of the proper shape
and size rarely formed; it appeared post-photopolymerization that the cell/prepolymer
solution did not properly fill the wells and that the wells were instead filled with air
bubbles. In contrast, cell-free microstructures formed adequately under the same
macromer concentration, photoinitiator concentration, and UV duration parameters
within PDMS micropatterns of features as low as 50 gm in diameter.
The parameter values (5% MeHA, 1% photoinitiator, 60 s UV exposure) found to be
most satisfactory for producing cell viable hydrogels with the thin-layer model produced
a noticeable quantity of debris when used to generate cell-laden microstructures. This
was visibly observed during experimentation to be a result of the physical stimulation
(the microstructures were pushed around with a micromanipulator to verify that they
were untethered) required to harvest free microstructures which was not required to
produce thin-layers of hydrogel. In the end, parameter values of 10% MeHA macromer
concentration, 1% photoinitiator, and 45 s UV exposure duration were found to be
acceptable for maintaining both cell viability and microstructure stability.
Our finding that initial viability with differing encapsulated cell densities (Figure 3.6)
remained relatively stable (>85%) was in line with expectations. However, longer term
viability may differ with respect to cell density if diffusion mediated nutrient/waste
exchange becomes limited. In these scenarios, the size of the microstructures would also
be expected to affect the capacity of diffusion-reliant processes to maintain cell viability.
In the future it may be useful to model as well as experimentally assess diffusion-limited
cell death. Diffusion-limited death does not appear to be relevant for the cell-laden 400
pgm (50 pm thick) square hexahedrons (Figure 3.8) used here, as there appears on the
fourth day to be no more cell death in the middle than near the periphery. Note that the
red cells in Figures 3.5-3.8 located around periphery of the microstructures are believed
to be adhered to the surface rather than embedded within the surface layers of the
microstructure since they were found to be mobile and detachable from the surface upon
physical contact with a micromanipulator.
Two phenomena remain unexplained which future work may aim to address. One is the
issue of cell distribution homogeneity within cell-laden microstructures. The
fluorescently stained cells in Figure 3.7 were qualitatively assessed to have fairly uniform
distributions with the exception of the confocal-produced side view (Figure 3.7E). It is
unclear from the data collected whether this is real and reproducible. The second
phenomenon is the existence of occassional microstructures exhibiting much lower
viability values than the majority of the other microstructures (lower right, Figure 3.8). It
may be of value in the future to determine whether this is reproducible, and if so, to
identify the cause so as to minimize these occurrences.
Taking a step beyond easy retrieval, microstructures generated using the
photocrosslinking technique were arranged into specific configurations. A representative
example is an alternating checkerboard pattern (Figure 3.9) assembled from fluorescently
red- and green-stained cells in separate sets of microstructures. This was performed by
physically directing individual microstructures into the pattern using a micromanipulator.
Although this operation was time-consuming due to difficulties encountered in
manipulating individual microstructures and unfeasible for bottom-up tissue engineering,
the successful ordered arrangement of shape-specific components containing different
cell types may be beneficial for generating cellular structures with controlled 3D
structures in vitro.
Figure 3.9: Microstructure arrangement and assembly. PKH26 (red) and CFSE
(green) stained cells were encapsulated in separate MeHA microstructures and
subsequently arranged in an alternating checkerboard pattern.
3.4 Conclusion
This work was originally undertaken as a general proof-of-principle of a technique for
which bottom-up tissue engineering was but one of multiple potential applications. As
such, we showed that it is possible to produce MeHA and PEGDA microstructures of
controlled size and shape with initial cell viabilities >85%. In the future, materials which
polymerize through alternative chemistries that do not require UV exposure such as 450
nm visible light9 7 may be beneficial for enhancing cell viability. We recognize that the
utilization this technique for bottom-up tissue engineering would necessitate more
rigorous and thorough characterizations than we have performed here of important
properties like reproduction fidelity, elasticity/plasticity as a function of cell density, and
cell viability as functions of cell type or microstructure size. Nonetheless, this work lays
out a facile technique for producing photocrosslinkable shape- and size-controlled
microstructures as well as identifying the important processing difficulties and
considerations that should be taken into account in future work. As such, micromolding
through UV photocrosslinking may potentially be a useful and important component in a
bottom-up tissue engineering strategy.
Chapter 4
Chemically Crosslinked Microstructures
The rapid crosslinking of hydrogel materials such as alginate which polymerize through
the addition of a secondary soluble factor (which we refer to as 'chemically
crosslinkable') requires a modification to the micromolding approach utilized for
ultraviolet (UV) light photopolymerizable hydrogels. The technique discussed in Chapter
3 involves initiating the crosslinking reaction (UV exposure) after the liquid prepolymer
has already been molded. Similarly for chemically crosslinked hydrogels, it is necessary
to introduce the crosslinking agent after molding so as to avoid producing masses of
partially crosslinked hydrogel that obstruct the molding process. This may be facilitated
by the use of a (crosslinking) agent-delivering agarose mold. By pre-loading the
crosslinking agent within the mold itself, the liquid prepolymer hydrogel can be
crosslinked post-molding by the diffusion of the agent out of the mold. To demonstrate
the efficacy of this controlled-release technique we focused on generating alginate
microstructures which polymerize with the addition of divalent calcium ions
(schematically illustrated in Figure 4.1). We furthermore verify its applicability by
producing alternate structures (such as patterned membrane) and using alternate materials
(pH-modulated chitosan).
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Figure 4.1: Photopolymerization of calcium alginate. Alginate consists of linear
chains of alternating (1-4)-linked B-D-mannuronate (M) and C-5 epimer a-L-guluronate
(G) blocks which can be stably crosslinked by divalent cations such as calcium. Since
crosslinking occurs at the G-blocks the relative number of G- and M-blocks dictate the
structural characteristics of crosslinked alginate networks.
The goal of this work is similar to Chapter 3 in that we intended to demonstrate a
controlled-release approach could feasibly generate free shape- and size-controlled
microstructures. While the processing requirements of the materials used in this work
(calcium alginate, chitosan) were essential in driving the motivation behind developing
this technique, the specific biological and mechanical properties were only dealt with
peripherally. This work was intended as a proof-of-principled of a controlled-release
technique for producing microstructures and microfeatures that could be used in any
number of applications (and so patterned membranes are also demonstrated). We fully
recognize that specific future applications such as bottom-up tissue engineering would
require more rigorous and comprehensive assessments of the biological and mechanical
properties of shape- and size-controlled microstructures. However, such
characterizations were considered beyond the scope of this particular work. Nonetheless,
most of the work was performed used calcium alginate (with only a brief demonstration
of producing chitosan microstructures) because it is commonly used in tissue
engineering43,99-101, drug delivery 102 -104, immunoisolation 1°0 5-'0 7  and cell
encapsulation 108,109 applications. Indeed, it has been shown to be stable over long periods
of time in vivo in both animals and humans110o. We have here assessed processing
parameters (crosslinker and macromer concentration) for their effects on gelation time
and initial cell viability in a particular (calcium alginate) model system. However, this
controlled-release technique may potentially be used with other similar chemically
crosslinked materials.
d Please note this work was carried out for publication as a 2-page Communication. The relative lack of
characterization data reflects this.
4.1 Materials and Methods
4.1.1 Cell Culture
All cells were manipulated under sterile tissue culture hoods and maintained in a 95%
air/5% CO 2 humidified incubator at 370 C. NIH-3T3 mouse embryonic fibroblast cells
were maintained in Dulbecco's modified Eagle media (DMEM) supplemented with 10%
FBS. Confluent dishes of NIH-3T3 cells were passaged and fed every 3-4 days. Murine
embryonic stem (mES) cells (R1 strain) were maintained on gelatin treated dishes with
media comprised of 15% ES qualified FBS in DMEM knockout medium. ES cells were
fed daily and passaged every 3 days at a subculture ratio of 1:4. AML12 murine
hepatocytes were maintained in a medium comprised 90% of 1:1 (v/v) mixture of DMEM
and Ham's F12 medium with 10% FBS. Confluent dishes of AML12 cells were
passaged and fed every 3-4 days.
4.1.2 Prepolymer Solutions
Alginate hydrogel precursor was prepared by dissolving alginic acid (Sigma) in cell-
culture media prepared as described above, or in ddH20 to obtain the desired final
concentration (1% w/v, 1.5% w/v, 2% w/v, 3% w/v, 4%w/v) at 370 C. For the preparation
of fluorescently-labeled alginate hydrogels, rhodamine (Sigma) or fluorescein
isothiocynate conjugated to bovine serum albumin (FITC-BSA, from Sigma) were
dissolved in ddH20 to obtain a concentration of 200gg/ml prior to addition of the alginic
acid. Chitosan hydrogel precursor was prepared by dissolving 2% w/v chitosan (practical
grade from crab shells, Sigma) in a pH 5.7 solution of hydrochloric acid (Fisher Scientific)
diluted in ddH20
4.1.3 Poly(dimethylsiloxane) (PDMS) Mold Fabrication
PDMS micropatterns of various shapes were fabricated by curing prepolymer (Sylgard
184, Essex Chemical) on silicon masters patterned with SU-8 photoresist. The patterns
on the masters had shapes in relief (squares, circles, long rectangles) of various sizes
(ranging from 20 to 400 pm) as well as in depth, so that molds with both wells and
protruding features could be produced. PDMS patterns were generated by pouring 1:10
curing agent to silicon elastomer onto the master and curing for 2 h at 70*C. Finally, the
PDMS patterns were peeled from the silicon masters, and cut into small rectangular
shapes. Before molding, the PDMS patterns were rendered hydrophilic by plasma
cleaning for 10 minutes on medium power (PDC-001, Harrick Scientific).
4.1.4 Agarose Mold Fabrication.
Agarose replicas were molded by pouring molten agarose on positive and negative SU-8
patterned silicon masters, as well as on flat surfaces to create patterned and flat molds,
respectively. Agarose solutions were generated by heating 4% w/w agarose (Aldrich) in
ddH20 until dissolved. For use with the alginate hydrogel precursor, CaCl 2 (Sigma) was
added to the molten agarose to obtain a final concentration of 10mM, 50mM, 100mM,
200mM or 500mM. For use with chitosan hydrogel precursor, the agarose mold was
removed from the SU-8 master, allowed to dry at room temperature overnight, and
hydrated in a bath of 5% NaOH (Sigma) in ddH20 for 5-6 hrs before use.
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Figure 4.2: Schematic of controlled release crosslinking technique. Replica molding
can be used to produce patterned membranes while microtransfer molding may be used to
generate free shape- and size-controlled microstructures. Note that the primary
difference between the two techniques is whether the crosslinker-loaded agarose is the
molded or flat piece.
4.1.5 Cell Encapsulation
For encapsulation experiments, cells were trypsinized with 0.23% trypsin and 0.13%
ethylenediaminetetraacetic acid (EDTA) in PBS (Gibco) and then centrifuged at 1000
rpm for 2 min to produce a cell pellet. The pellet was then resuspended in the
prepolymer solution at 8 x 106 cells/ml (this choice was arbitrary-we intended only to
show cells encapsulated within the hydrogels).
4.1.6 Replica Molding and Micro-Transfer Molding (uTM)
Replica molding was used to produce micropatterned hydrogel membranes. The
hydrogel precursor was poured on top of a flat substrate, and an agarose mold containing
the gelling agent was applied directly to the liquid hydrogel precursor. To produce the
structures seen in Figure 4.6B, replica molding was used to produce PKH-26 (Sigma)
stained AML-12 cells loaded within patterned membranes. Cell-tracker blue (Invitrogen)
stained mES cells were then deposited atop the patterned membranes with excess cells
(outside of the wells) gently scraped away using a coverslide To produce the structures
seen in Figure 4.6C, a FITC-loaded (10% w/w in alginate precursor) membrane was first
produced using replica molding. A secondary rhodamine-loaded (10% w/w) precursor
was then molded (gelled for 4 min) atop of the membrane using a flat agarose slab
containing the gelling agent. Micro-transfer molding (pTM) was employed to obtain free
microstructures. A thin layer of hydrogel precursor was coated over the PDMS mold;
after briefly (-30s) degassing in a vacuum chamber (PDC-001, Harrick Scientific) and
scraping away excess material, the agarose slab containing the gelling agent was pressed
against the mold. This procedure was required to overcome the weak seal formed
between PDMS and agarose, which otherwise led to the formation of a continuous film.
4.1.7 Harvesting ofFree Microparticles
After gelling, the agarose slab was removed to retrieve the free microstructures. In this
process, most pieces remained attached to the microwells. After hydrating the
microstructures upon the mold, a number of individual pieces spontaneously detached
from the microwells. To remove any remaining pieces, a pipette tip was gently brushed
over the surface the mold.
4.1.8 Imaging and Analysis
Phase contrast and fluorescent images were taken on a Nikon TE2000 fluroescent
microscope. Cell viability within the microstructures was assessed using live/dead stain.
The microstructures were stained with 200 pl PBS solution containing 2 ýtg/ml calcein
AM and 4 pg/ml ethidium homodimer-1 (Molecular Probes) and visualized under
fluorescein isothiocynate (FITC) and tetramethyl rhodamine iso-thiocyanate (TRITC)
filters. Two recognized parameters of cell viability - intracellular esterase activity and
plasma membrane integrity - were tracked. Live cells fluoresced green, showing
intracellular esterase activity that hydrolyzed the fluorogenic esterase substrate (calcein
AM) to a green fluorescent product, and dead cells fluoresced red, their plasma
membrane being compromised and therefore permeable to the high-affinity, red
fluorescent nucleic acid stain (ethidium homodimer-1). Co-cultured cells were labeled
using PKH26 (Sigma) and CellTracker Blue (Invitrogen) dyes, and processed according
to the manufacturer specifications.
4.1.9 Cell Viability Measurements
To assess the effects of the fabrication process on encapsulated NIH-3T3 cell viability,
cells were suspended in 4% w/v alginate precursor solutions and molded into
micropattemrned membranes. Percent viability values were calculated by counting the
number of live (green) cells and the number of dead (red) cells in a representative
1500tm x 1000lm rectangular area magnified at 4X and dividing the number of live
cells by the number of total cells (live plus dead). Measurements were taken in
quadruplicate, and error bars were based on standard deviation values for n=4.
4.2 Results
4.2.1 Cell-Free Microstructures
As shown in Figure 4.3, 4% w/v calcium alginate (Figure 4.3A, 4.3B) and 2% w/v
chitosan (Figure 4.3C, 4.3D) could be polymerized for 4 min to generate patterned
membranes as well as shape- and size-controlled microstructures as small as tens of
microns. These representative structures exhibit roughly (qualitatively) sharp corners
with what appear to be minor imperfections along the edges of the microstructures
(Figure 4.3B, 4.3D).
Features in Relief Free Microparticles
Figure 4.3: Photomicrographs of free microstructures and patterned membranes.
Replica molding generated patterned (A) calcium alginate and (C) chitosan membranes
with features in relief while JTM generated (B) calcium alginate and (D) chitosan
microstructures.
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4.2.2 Polymerization Properties
We investigated the effect of alginate concentration in the hydrogel precursor as well as
agarose and calcium chloride concentration in the mold on the polymerization properties
of the microstructures (Figure 4.4). Increases in both alginate precursor concentration
and agarose Ca2+ concentration are shown to vary inversely with the time required to
form mechanically stable structures.
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Figure 4.4: Polymerization time as a function of alginate concentration. The data
shows the time required to achieve complete gelation using replica molding under
varying alginate and CaCl2 concentrations. In general, higher calcium and alginate
concentrations facilitate shorter gelation times.
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4.2.3 Initial Cell Viability
Initial cell viability (Figure 4.5) measurements were made with a fixed alginate
concentration of 4%. This data indicates uniformly high cell viabilities for the parameter
ranges tested with the exception of 500 mM calcium for 2.5 minutes.
Figure 4.5: Cell viability as a function of calcium concentration and gelation time.
Initial encapsulation viability of NIH-3T3 in 4% alginate w/v under varying CaCl2
concentrations and molding times. With the exception of the 500 mM / 2.5 min data point,
cell viability remains relatively uniform at -80%.
4.2.4 Cell- and Soluble Factor-Laden Microstructures
To illustrate the potential utilization of this controlled release technique for producing
cell-laden shape- and size-controlled microstructures, cells were encapsulated in
rectangular hexahedron microparticles (Figure 4.6A). Though considered outside of the
scope of this work, it was qualitatively observed that the mechanical properties of the
microstructures appeared to vary with the precursor concentration. The ability to produce
various other structures (not relevant to bottom-up tissue engineering) is demonstrated
using the controlled-release technique as well. In Figure 4.6B, the potential use of cell-
laden micromolded hydrogels to control cell-cell interactions in vitro is shown. Here,
Cell-Tracker Blue stained mouse embryonic stem cells (blue) were seeded within
microwells formed from alginate hydrogels embedded with PKH26 stained AML12
hepatocytes (red). To produce the structures seen in Figure 4.6C, the controlled-release
technique was used to produce multilayered soluble factor-loaded hydrogel constructs by
sequential molding of hydrogels. Finally, free alginate microstructures containing a
fluorescence FITC-BSA marker are shown in Figure 4.6D.
Figure 4.6. Fluorescent images of various microstructures. (A) Micrograph of NIH-
3T3 cell-laden microparticles overlayed with live/dead staining (green/red, respectively).
The yellow represents a cell which stained both green and red; yellow presumably
indicates that a cell that was initially alive died before imaging. (B) Co-culture of
AML12 cells, stained with PKH26 (red) and mES cells, stained with CellTracker Blue.
AML12 cells were encapsulated within the alginate membrane, while mES cells were
seeded within wells. (C) Composite structures of FITC (green) and rhodamine (red)
loaded alginates and (D) alginate microparticle loaded with FITC-BSA are also shown.
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4.3 Discussion
4.3.1 Polymerization Properties
Gelation time was hypothesized to be an important parameter since extremely long
durations may not be compatible for maintaining high cell viability in encapsulation
applications. Therefore, we measured the minimum time required for the formation of
mechanically stable structures (that could be easily handled and spontaneously released
from the agarose mold) under each set of conditions. The key conclusion we drew from
these results was that gelation time within the range of parameters tested appears well-
suited for cell encapsulation. Even the lowest alginate and calcium concentrations tested
yielded a gelation time of only 90s (as opposed to many hours).
4.3.2 Initial Cell Viability
From our experiments (Figure 4.4) 90 s was determined to be a reasonable ceiling for
gelation time and so our cell viability (Figure 4.5) data range did not extend beyond 2.5
minutes. Integration of data from both figures 4.4 and 4.5 imply that there is a wide
parameter range in terms of calcium and alginate concentrations in which it is possible to
maintain high cell viabilities. Therefore, these processing conditions should not limit the
cell viability of alginate microstructures produced using this controlled-release technique.
4.3.3 Cell- and Soluble Factor-Laden Microstructures
Though Figure 4.6A demonstrates the ability to encapsulate cells within free shape- and
size-controlled microstructures, important questions regarding biological performance
remain unresolved. Chief among them is viability over time which, due to diffusion
limitations, we would expect to vary as a function of the size and shape of the
microstructure. Reproduction fidelity (rough edges in Figure 4.3) and mechanical
characteristics as a function of polymer and calcium concentration (not to mention cell
density) also remain unexplored.
With the exception of Figure 4.6A, the structures shown in Figure 4.6 are not compatible
with bottom up tissue engineering. The original intent of the work was to present the
concept of the controlled-release technique and to demonstrate the range of interesting
and potentially useful structures that could be produced. As such, the setup in Figure
4.6B was intended to suggest the potential co-culture of one type of cells with another
immobilized supporting type, Figure 4.6C novel cell and material patterning applications,
and Figure 4.6D drug delivery applications.
4.4 Conclusion
The controlled-release technique represents the second of two methods discussed in this
thesis for fabricating shape- and size-controlled microstructures. While in this work we
focused on assessing processing conditions for cell-loaded calcium alginate
microstructures, the technique we present, based on replica molding or tTM by
controlled release of the gelling agent, was also demonstrated with pH dependent
chitosan hydrogels. For bottom-up tissue engineering, comprehensive and rigorous
biological and mechanical characterization work must be performed on free
microstructures. Nonetheless, we believe this controlled-release soft lithographic
technique is practical to implement and useful for producing shape- and size-controlled
microstructures.
Chapter 5
Cell-Laden Agarose Microfluidics
This chapter discusses the fabrication and characterization of cell-laden agarose
microfluidic devices that maintain cell viability through diffusion-based nutrient/waste
exchange. In this soft lithographic fabrication technique, cells were suspended in low-
temperature molten agarose and molded on an SU-8 patterned silicon wafer to generate
channel features. To seal the two pieces of agarose to form microchannels, they were
placed on a glass coverslip and heated on a hot plate so as to slightly melt the bonding
interfaces. The two slightly melted surfaces were then annealed to one another to form
water tight microchannels.
Although microfluidics devices have traditionally been fabricated from dry non-hydrogel
polymers"', agarose is not the first hydrogel to be used for microfluidics. Recently,
calcium alginate75 and gelatin 89 hydrogels were reported. But in these papers, the extent
of the biological work was limited to cells seeded on the surface of microchannels. The
work documented in this chapter is to our knowledge the first involving the formation of
cell-containing microfluidic hydrogels for diffusion-based nutrient/waste exchange.
Agarose is a thermally reversible polysaccharide consisting of alternating copolymers of
61(1-3)-linked f3-D-galactose and (1-4)-linked (3-6)-anhydro-a-L-galactose 61. It can be
induced to melt or gel in a variety of temperatures ranging from 17 'C to 80 'C depending
on the molecular weight and chemical modification of side groups. Agarose hydrogels
are commonly used in a variety of biological and biomedical applications and are used
ubiquitously in electrophoresis applications"12 for their ability to control the diffusion of
biological moieties. Importantly for this work, agarose is amenable for soft lithography
113,114 and can be used to produce micropattern surfaces. In addition, cell encapsulation in
agarose has been used for a variety of applications ranging from biosensing to
therapeutics 53,115 and agarose has been shown to be biocompatible when implanted in
116 i gr de o ncnbvivo 1. While agarose does not directly provide an active attachment substrate, it can be
supplemented with collagen or gelfoam to provide attachment sites for anchorage-
dependent cells 61
The goal of this work was to present a microfluidic technique for facilitating
nutrient/waste exchange in macroscale tissue engineering constructs. Agarose has not
previously been shown to be useful as a microfluidic material but its physical and
biocompatibility properties are extremely well-characterized in the literature61. Therefore,
we focused in this work on the specifics of its application as a microfluidic biomaterial
by showing the diffusion of molecules from the microfluidic channels into the
surrounding bulk material as a result of flow through channels. Furthermore, we show
that encapsulated cells exhibit a zone of high cell viability (in comparison to controls)
around the microchannels after 3 days of continuous flow of media through the
microchannel. Because this is the first use of microfluidics for facilitating nutrient/waste
exchange for cells in the surrounding bulk material, the work did not aim to provide a full
characterization of the system.
5.1 Materials and Methods
5.1.1 Cell Culture
AML-12 murine hepatocytes were kept at 37 TC in a 95% air/5% CO2 incubator and
maintained in 45% Dulbecco's Modified Eagle Media (DMEM), 45% Ham's F12 Media,
and 10% Fetal Bovine Serum (FBS). Confluent flasks of AML-12 cells were passaged
and fed every 3-4 days.
5.1.2 Agarose Mold Fabrication
Agarose replicas (1 cm thick, so as to provide sufficient mechanical stability to allow
handling) were molded by gelling molten agarose solution on the positive microchannel
features of SU-8 patterned silicon masters (Figure 5.1). Agarose solutions were generated
by heating Low Gelling Temperature Agarose (Type VII-A, Sigma) in Phosphate-
Buffered Saline (PBS) until dissolved. For experiments in which cells were embedded
within agarose, 6% agarose (autoclaved/sterilized to dissolve in PBS) was allowed to
cool to 70 TC and supplemented with equal volume of cell suspension in media (cells at
controlled densities) to yield a 3% agarose mixture loaded with cells. The molten
agarose-cell mixture was then poured onto the silicon master and allowed to gel for 2 h at
250 C in a sterile tissue culture hood. To form the base of the microchannel, a thin flat
slab of agarose was fabricated in a plastic culture dish. The agarose molds were gently
peeled from the silicon masters and trimmed to a suitable shape. To make holes for inlets
and outlets, a metal feeder wire of -2 cm in length was used as a guide for insertion of
the flexible polyethylene tubing (inner diameter 0.58 mm, outer diameter 0.965 mm,
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Figure 5.1: Schematic of the fabrication of agarose microfluidic devices with (right)
and without (left) embedded cells.
agarose
Becton Dickinson). Finally, the agarose molds were heated on glass slides on a hot plate
for 3 s at 71 TC and pressed against one another to form sealed microfluidic channels.
The device was allowed to cool for 10 min before fluid was introduced into the channel.
The processes involving cells were maintained under sterile conditions.
5.1.3 Channel Flow Experiments
To control the flow rate of fluids through the microchannel, the agarose microfluidic
device was connected to a syringe pump (AL-1000, World Precision Instruments) via
flexible polyethylene tubing. The channel effluent was removed by collection from an
outlet tube connected using a procedure similar to that of the inlet tube.
For experiments in which AML-12 hepatocytes were embedded at 2 x 106 cells/ml
(density given as cells within pre-gelled agarose) in microchannels, medium was pumped
through 150 tm deep x 800 gm wide channels at a rate of 10 p1l/min. Sterile conditions
were maintained throughout the fabrication and operation of the microfluidic device by
fabricating and operating the device entirely within a biosafety cabinet. For time
dependant studies, the entire apparatus was kept inside a sterilized vessel placed within
an incubator at 37 oC and 95% air/5% CO2.
5.1.4 Sectioning and Analytical Techniques
Channel flow and diffusion were verified by flowing fluorescein isothiocyanate
conjugated to bovine serum albumin (FITC-BSA, green fluorescence, excitation/emission
= 506/529 nm) through (cross-sectional area) 220 gm x 100 gm microchannels at a rate
of 100 il/min. To qualitatively assess diffusion into the surrounding agarose, intensity
measurements were calculated from fluorescent images taken every minute for 45 min.
These fluorescent intensities, which were taken at a fixed distance from the channel
boundary using fixed optical and image capture parameters, were then processed.
Specifically, the images were registered, cropped, and averaged over the length of the
channel using MATLAB. The fluorescence intensities, assumed to be proportional to the
concentration of FITC-BSA, were normalized to the mid-channel intensities of each
captured image to account for increasing intensities in progressive images caused by
diffusion into the ceiling and floor of the channel.
Initial cell distribution throughout cell-loaded devices was visualized by incubating cells
with CFSE (carboxyfluorescein succinimide ester) stain for 15 min prior to encapsulation
followed by fluorescence microscopy after device fabrication. Cell viability within the
microchannels was assessed by applying a live/dead fluorescence assay to slices of
agarose microchannels with encapsulated cells. To analyze agarose cross-sections, slices
were gently removed with a flat razor blade into - 1 mm thick sections. Live/dead stain
was applied directly to the slices, which were incubated for 10 min and visualized under a
fluorescent microscope (Nikon, TE2000). Two recognized parameters of cell viability-
intracellular esterase activity and plasma membrane integrity-were tracked with the
live/dead stain, consisting of PBS solution containing 0.5 pg/ml calcein AM and 2 pg/ml
ethidium homodimer-1. Live cells fluoresced green due to intracellular esterase activity
that hydrolyzed the fluorogenic esterase substrate (calcein AM) to a green fluorescent
product. Dead cells fluoresced red since their compromised membranes were permeable
to the high-affinity red fluorescent nucleic acid stain (ethidium homodimer-1).
Percent viability values of slices were calculated by counting the number of live (green)
cells and the number of dead (red) cells in zones above each channel magnified at 4X.
Viability data were taken in triplicate for any given condition from the beginning (0 cm),
middle (1.5 cm), and end (3.0 cm) of channels. In Figure 5.6B, values were obtained for
each control or experimental condition (n = 9 for each value, an average of 230 cells/zone)
by dividing the number of live cells by the total number in a 1.25mm x 1.25mm zone
above the channels. To average the potential effect of nutrient depletion on cell viability
along the axial length of the channel, sections were taken in triplicates from three axial (0
cm, 1.5 cm, 3.0 cm) sections of the channel (resulting in n = 9 for each data point).
Percent viability values for Figure 5.6C were determined in a similar manner except that
that the data was binned into 5 vertical zones (demarcated in Figure 5.6A) of 1.25 mm x
0.25 mm each (n = 9 for each value, an average of 46 cells/zone). The exception is that
the initial viability value shown in Figure 5.6C was obtained from the 1.25 mm x 1.25
mm square zone located above the channel (n = 9). To determine the viability of cells in
channels as a function of both axial distance along and vertical distance away from the
channel, the viability of cells within 1.25 mm x 0.25 mm zones are reported (n = 3 for
each value, an average of 46 cells/zone) in Figures 5.7-5.14. Zones were defined at
various vertical distances (50 ý±m, 300 .tm, 550 ptm, 800 pm, 1050 pm; the labeled values
indicate the distance from the channel floor to the floor of the zone) and axial distances
(0.0 cm, 1.5 cm, 3.0 cm). Paired t-tests were used to assess statistically significant
differences in viability. Due to potential human error in cell counting we considered p <
0.005 to be statistically significant (conservative when compared to p < 0.05 used in
many typical biological experiments).
5.2 Results
5.2.1 Channel Fabrication
The important parameters for channel sealing, agarose concentration and heating, are
explored in Figure 5.2. It appears that the degree of heating required to produce sealed
microchannels increases with increasing agarose concentrations. Using agarose of any
given concentration, low heating resulted in imperfectly sealed and leaky microchannels;
however, excessive heating resulted in melted channel features. In addition, lower
concentrations produced moderately transparent but weak bulk materials which tended to
fracture upon even careful handling, while higher concentrations produced more opaque
(hinders microscopy) but also more robust bulk materials. From these experiments, an
agarose concentration of 3% was accepted as both sufficiently transparent for imaging
and sufficiently robust for careful mechanical handling. At this concentration, 3 s of
heating at a temperature of 71TC was found to adequately seal channels while avoiding
melting of features.
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Figure 5.2: Characterization of agarose concentration and melting time for sealing
of surfaces. Circles indicate that channel features were unmelted, and squares indicate
melting. Dashed lines mark the boundary between melted and unmelted features and
between structurally stable and unstable agarose, where stability was defined as the
ability to maintain channel features in the agarose without tearing or deformation. The
circled region indicates the chosen experimental conditions.
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Figure 5.3 shows that agarose microchannels of different sizes and aspect ratios from 50
gm wide by 70 tm tall (Figure 3A) to 1000 pm wide by 150 gm tall (Figure 3B) can be
fabricated. The channel in Figure 5.3B demonstrates that 3% agarose, at an elastic
modulus reported between 19 and 32 kPA 117,118, is sufficiently rigid to support a large
aspect ratio channel without noticeable deformation. While there appear to be black
spaces at the interface of the two agarose slabs; we believe these to be optical artifacts.
They are likely a product of our sectioning technique (impossible to manually produce
perfect Imm thick slices) as well as the lack of complete melting of the two surfaces
upon attachment. Despite the presence of this black edge in light microscopy the devices
are known to be sealed as the channels have been verified as sealed in dozens of flow
experiments with tracer dyes.
Figure 5.3: Light micrograph cross sectional images of agarose channels. Channels
(A) 50 pm in width x 70 jtm in height and (B) 1 mm in width x 150 jtm in depth are
depicted.
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To visualize the diffusivity of molecules as a result of flow through 3% agarose
microchannels, a series of fluorescent images were taken at 1, 5, and 30 min (Figure
5.4A). The immediately visible and sharply defined boundaries of fluorescence in
Figure 5.4A at 1 minute indicate proper sealing. By 30 min into flow conditions,
diffusion of FITC-BSA (MW 69 kDa) into the surrounding channel material is apparent.
As graphed in Figure 5.4C, the fluorescence intensity rises with time at any given
distance from the channel..
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Figure 5.4: Diffusion of FITC-BSA into surrounding agarose. The series of top-down
fluorescent images with corresponding phase image in (A) qualitatively depict diffusion
with time. In (B) the phase and corresponding fluorescent image of the cross-section of a
channel 30 min after FITC-BSA flow are shown. Overlaid intensity profiles (C) are
plotted for times ranging from 1 min to 45 min.
5 minutes
5.2.2 Cell Encapsulation within Agarose
Figure 5.5 shows a microfluidic channel in which cells were embedded within the bulk
material of the molded upper layer but not within the bulk material of the flat bottom
layer. Light microscopy (Figures 5.5C, 5.5D) and CSFE-labeled fluorescence (Figures
5.5A, 5.5B) images of encapsulation reveal a fairly homogeneous distribution of cells
throughout the molded bulk agarose material. Further observation of sections of different
channel regions (not shown) indicated that the cells were homogeneously distributed
throughout the rest of the device as well.
Figure 5.5: Fluorescent and brightfield micrographs of CFSE-stained cells
embedded in an agarose microchannel. Panels A and C show a channel from above
while panels B and D show the cross-sectional image of another channel. Dotted lines
were added to the images to facilitate visualization at print resolutions.
5.2.3 Viability ofEncapsulated Cells
Please note that while Figure 5.6 sums up the interesting viability findings and presents
them for comparative purposes, more detailed data is reported in Figures 5.7-5.14. Upon
formation of microchannels, cell culture media was pumped through the channels for up
to three days. The flow rate of 10 Al/min yielding a shear stress value of 1.18 Pa (using
previously described method 119) was chosen because it falls within the physiological
shear stress range of mammalian arteries (0.51 - 5.0 Pa 120).
As shown in the left panel of Figure 5.6A, the majority of cells were viable upon initial
device fabrication. Control experiments that exposed trypsinized but unencapsulated
cells to identical processing temperatures (as high as 70 oC, including cooling time)
exhibited similar viability values (-85%). The live/dead staining indicates no
disproportionate degree of cell death at the adherent boundary between the two agarose
pieces, indicating that the brief surface heating (71 oC for 3 s, to facilitate bonding of the
two pieces) did not cause additional cell death.
From the no-flow and PBS flow controls (Figure 6B), it appears a fraction of cells are
able to survive up to 3 days with no nutrient delivery. However, viability results under
experimental conditions in which media was continuously pumped through the device
show statistically significant increases between experimental and the two control
conditions for day 1, day 2, and day 3. By day 3, the difference between experimental
and the two control conditions was dramatic. While there were significant drops in
viability between each day up to day 2, there was no significant difference in the viability
of the either control condition between days 2 and 3. Additionally, PBS flow control
viability values exhibit statistically significant differences in time-course viability when
compared to the values obtained under no-flow control condition on days 1 and 2; this
difference disappears by day 3.
No significant variations in viability with respect to distance above the channel were
observed immediately after the encapsulation process (Figure 5.6C, 50 ttm). Over time,
cells further from the microchannel gradually lost viability, as shown in a representative
image from day 3 in the right half of Figure 5.6A in which zones further from the channel
may be qualitatively compared to the zones that are closer. To quantitatively assess the
effect of distance above the microchannel as a function of time under experimental
conditions, the percent viability of zones roughly 1.25 mm x 0.25 mm (visualized in
Figure 5.6A by dashed white lines) centered atop and binned at progressively greater
distances above the channel are plotted individually in Figure 5.6C. This data shows
significantly larger drops in viability over time for regions at greater (1050 pm) distances
from the channel. In the region closest to the channel (50 pm), there is a small (in
comparison to regions at greater distances) but significant drop in viability on day 1 in
comparison to initial viability, but no significant differences are found between day 1 and
2 or between 2 and 3.
Detailed PBS control (Figures 5.7 - 5.9) and experimental media flow (5.10 - 5.14)
viability data are reported to assess the possibility of nutrient depletion along the axial
direction (direction of flow) of the channel. For each time point (day) and condition
(PBS/experimental), no statistically significant differences were found between zones of
different axial distances along the channel (left panel in Figures 5.7-5.9). These three
axial values were therefore binned and plotted together (n = 9, right panel in Figures 5.7-
5.9).
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Figure 5.6: Quantification of cell viability in the agarose microchannels over time.
The images in (A) are representative live-dead staining of AML-12 murine hepatocytes
encapsulated in agarose channels after 0 (left) and 3 days (right). Rectangular regions
demarcated by dashed white lines correspond to -250 p~m thick zones where the labeled
height values correspond to the mean distance of each zone above the channel floor. The
graph in (B) plots percent viability values for initial (n=27) as well as for up to three days
under 2 control conditions (No Flow, PBS Flow) and experimental media flow conditions
(n=9 for all three conditions). In part (C) the time course viability under experimental
media flow conditions for 1.25 mm x 0.25 mm zones of progressively increasing
distances (50 gm, 300 gm, 550 gm, 800 gm, 1050 gm) from the channel are shown (n=9).
Error bars span one standard deviation from the mean.
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Figure 5.7: Viability data for PBS flow control experiments at day 1 in zones binned
by vertical distance above and axial distance along the channel (left panel, n=3) as well as
only by vertical distance above the channel (right panel, n = 9). Error bars span 1
standard deviation from the mean.
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Figure 5.8: Viability data for PBS flow control experiments at day 2 in zones binned
by vertical distance above and axial distance along the channel (left panel, n=3) as well as
only by vertical distance above the channel (right panel, n = 9). Error bars span 1
standard deviation from the mean.
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Figure 5.9: Viability data for PBS flow control experiments at day 3 in zones binned
by vertical distance above and axial distance along the channel (left panel, n=3) as well as
only by vertical distance above the channel (right panel, n = 9). Error bars span 1
standard deviation from the mean.
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Figure 5.10: Viability data for media flow experimental conditions within a 1.25mm
x 0.25mm zone 50 pm above the channel floor. Axial distance as well as time course
data are plotted (n = 3). Error bars span 1 standard deviation from the mean.
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Figure 5.11: Viability data for media flow experimental conditions within a 1.25mm
x 0.25mm zone 300 pm above the channel floor. Axial distance as well as time course
data are plotted (n = 3). Error bars span 1 standard deviation from the mean.
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Figure 5.12: Viability data for media flow experimental conditions within a 1.25mm
x 0.25mm zone 550 jtm above the channel floor. Axial distance as well as time course
data are plotted (n = 3). Error bars span 1 standard deviation from the mean.
Experimental 800 pm
100%
90%
80%
70%
00%
50%
40%
30%
20%
10%
WA
e: P y 1 ' b* lr( Ny 1),ý)* Ny' I), " 1ý4ý 1
Day 0 Day 1 Day 2 Day 3
Figure 5.13: Viability data for media flow experimental conditions within a 1.25mm
x 0.25mm zone 800 jLm above the channel floor. Axial distance as well as time course
data are plotted (n = 3). Error bars span 1 standard deviation from the mean.
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Figure 5.14: Viability data for media flow experimental conditions within a 1.25mm
x 0.25mm zone 1050 pm above the channel floor. Axial distance as well as time
course data are plotted (n = 3). Error bars span 1 standard deviation from the mean.
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5.3 Discussion
5.3.1 Channel Fabrication
While soft lithography has previously been used to mold agarose 113,'114 this work is to our
knowledge the first demonstration of an agarose microfluidic device. Proper channel
sealing is a non-trivial problem in soft lithography-based microfluidics, and so the initial
question was whether sealing would be possible using agarose. Fortunately, the gelation
of agarose can be reversed by thermal modulation, allowing for the sealing of channels
by semi-melting surfaces before bonding.
Based on the well-known properties of agarose121, our finding that stiffness and melting
temperature tended to increase with increasing agarose concentration was in line with
expectations. But this implies an important drawback of agarose as a microfluidic
material-at lower concentrations it is fairly difficult to peel away from the mold without
tearing. Though concentrations of higher than 3% might have further improved
mechanical stability and decreased the likelihood of tearing during handling, this
consideration was overridden by the downside of having to treat agarose surfaces to
much higher, potentially cytotoxic temperatures, to facilitate bonding.
High porosity and ease of molecular diffusion are crucial for maintaining the viability of
encapsulated cells since diffusion facilitates efficient nutrient delivery and waste removal.
Though the plots somewhat resemble typical diffusion curves, they cannot be construed
as actual diffusion profiles; this fluorescence microscopy technique is not amenable for
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obtaining reliable diffusivity values (in the literature, D-6.4 x 10-7 cm 2/S 122) since
diffusion into the ceiling and floor of the channel skews the shape of the curves.
5.3.2 Viability of Encapsulated Cells
Due to processing requirements (cell-loaded devices were set for 2 hours to facilitate
agarose gelation), the devices were fabricated with media (at 50%) to prevent
compromise of initial cell viability. However, this introduced the likelihood of a partial
maintenance of cell viability by pre-loaded rather than delivered media. This is likely the
reason that cell viability did not drop to 0% under PBS flow and no flow control
conditions even after 3 days.
The PBS control experiments were run to assess the effect of waste removal on cell
viability. It is important to note that we cannot in these experiments segregate the effect
of waste removal from dilution of the pre-loaded media; however, one reasonable
explanation for the PBS results when compared to no-flow is that the initial (days 1 and 2)
increases in viability are due to waste removal, which becomes insignificant by day 3.
Therefore, the effect of waste removal in improving cell viability in this system does
appear to overwhelm the detrimental effect of nutrient dilution in the first 2 days.
It is important to note that since the viability values of the two control conditions in
Figure 5.6B were taken from a 1.25 mm x 1.25 mm region above the channel the
experimental values were also taken from corresponding regions. However, by days 1-3
there is a distinct drop in cell viability at increasing distances above the channel. The
high viability of the region nearest the channel is therefore attenuated by lower viabilities
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farther away from the channels; this phenomenon necessitated the finer binning of data in
Figure 5.6C. These findings (higher viability near the channel) were likely the result of
diffusion limitations within the bulk agarose, preventing adequate nutrient and waste
exchange to cells embedded at larger distances from the microchannel. This property is
shared by the natural vasculature of tissues (capillaries in human tissues are typically
found -200 [tm apart).
The finely binned results in Figures 5.7-5.14 indicate that nutrient depletion, or
alternatively, waste accumulation, did not appear to impact cell viability within statistical
error along the length of the channel used. This result is expected since the residence
time of any particular volume of media within the channel (which can be modulated by
adjusting flow rate) is less than half a minute. However, limitations due to axial nutrient
depletion and waste accumulation would be expected to affect cell viability for longer
channels and slower flow rates.
5.3.3 Future Work
The purpose of this work was to assess the capacity for a cell-laden agarose microfluidic
system to facilitate cellular nutrient/waste exchange within the surrounding material. In
the future it may be valuable to rigorously assess questions such as pressurization of the
microchannels and shape maintenance over time. Furthermore, modeling of diffusion
and cellular metabolism (as a function of cell type and density) would provide a more
solid theoretical basis for choosing flow rates and the rational design of channel shape,
size, length, and (in biomimetic microfluidic networks) distances apart.
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The lithographic approach presented here is potentially compatible with other agarose
mixtures. To overcome the absence of an attachment matrix, the agarose could be
supplemented with ECM additives such as collagen or gelfoam. Signaling molecules
may also be incorporated within the hydrogel, either dissolved within the liquid phase or
conjugated to agarose via a Williams ether synthesis (attachable to amine group of
ligand) 123. Alternatively, the use of natural ECM molecules such as hyaluronic acid or
collagen may provide a more chemically and mechanically in vivo-like environment,
leading to superior assimilation of the resulting structures into the host tissue and cell
migration and proliferation within the hydrogel matrix.
Cell-laden agarose microfluidic hydrogels can also be scaled up. In this process,
biomimetic vascular patterns may be fabricated and stacked layer-by-layer, one upon
another to generate multi-layer vascularization in many discrete planes. However, the
basis for rational design of such a network would necessitate much work in modeling and
empircally characterizing the mass transport of macromolecules from microfluidic
channels into the surrounding material.
5.4 Conclusion
In summary, we have developed a soft lithographic technique for fabricating cell-laden
agarose microfluidic devices. We have characterized the degree of surface heating
necessary to form sealed channels and demonstrated flow within as well as diffusion into
the surroundings of the microchannels. In addition, cells were embedded homogeneously
within the agarose devices. The delivery of media from the channels allowed cells in
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close proximity to the channels to remain significantly more viable than control
conditions for up 3 days. This simple method may be useful as a means of generating
synthetic vasculature within tissue engineered constructs.
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Chapter 6
Future Work: Mesoscale Self-Assembly
This thesis described three techniques for producing cell-loaded structures that could be
used for tissue engineering. In chapters 3 and 4 two methods for producing UV
photocrosslinkable and chemically crosslinked shape- and size controlled microstructures
were described. These works were originally aimed at creating structures that may be
useful for a number of applications, but we here considered them primarily for their
potential utilization as components in bottom-up tissue engineering. Though further
characterization would be required before these microstructures could be used in self-
assembly, we have demonstrated the techniques to be generally capable of producing
shape- and size-controlled components with reasonable shape fidelity and cell viabilities.
Chapter 5 described a technique for generating cell-loaded agarose structures that can be
perfused by microfluidic channels. The results indicated that nutrient/waste exchange via
diffusion from the channels can play a positive role in cell maintenance. The discussion
of future work for further extending this general strategy for perfusion of tissue
engineered constructs was straightforward and was therefore presented within Chapter 5
itself. However, a proper discussion of self-assembly for bottom-up tissue engineering
would be substantially more involved. As such, it was restricted to this chapter.
The development of bottom-up tissue engineering requires the achievement of two
essential objectives. Chapters three and four of this thesis describe the two strategies for
generating shape- and size-controlled cell laden microstructures that constitute the
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realization of the first of these two objectives. The purpose of this final chapter is to
propose future work aimed at realizing the second objective: to develop methods for
directing self-assembly of shape- and size-controlled microstructures into meso- and
macroscale constructs.
Inspired by experimental observation of elf-assembling phenomena in biological systems,
a series of experiments carried out in the past decade have demonstrated the viability of
mesoscale self-assembly 124. At the molecular scale, self-assembling phenomena are
typically driven by reversible and relatively weak forces like van der Waals and Coulomb
interactions, hydrophobic interactions, and hydrogen bondingl 25126. In larger size
regimes, similar phenomena may be reproduced by harnessing forces such as steric,
entropic, magnetic, gravitational, and electrostatic interactions 125
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Figure 5.1: Mesoscale self-assembly. This set of schematics and images are taken from
the Whitesides Group127. Metallic plates with hydrophobically functionalized surfaces
(indicated in the schematic by darker surfaces) are coated with a liquid hydrophobic film.
When agitated in an aqueous solution the coalescence of microstructures at the coated
faces minimizes hydrophobic / hydrophilic interfacial areas thereby driving spontaneous
self-assembly into consistent and reproducible ordered three-dimensional arrays.
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Recent work at these larger size scales has shown that shape-fitting millimeter scale
components can be self-assembled (with or without shaped templates) at floating and
fluid-fluid interfaces 128,129 as well as in aqueous suspensions77' 130, 131 by the clever
exploitation of capillary forces, typically using liquids with high interfacial free energy
(examples shown in Figure 5.1). For example, free units of hexagonal plates (hexagons
were used to minimize the number of potential slip planes) floating at a water-
perfluorodecalin interface were shown to spontaneously self-assemble into a honeycomb-
like lattice 128. Perhaps more importantly for bottom-up tissue engineering, components
of a few hundred microns (the relevant size regime for bottom-up tissue engineering as
proposed here) fabricated through photolithography have been self-assembled into
ordered arrays via capillary interactions 132. These experiments were motivated by
potential applications in the microelectronics device industry and so demonstrate self-
assembly of non-hydrogel polymeric and metallic microstructures in highly cell toxic
environments; the self-assembly of cell encapsulation-compatible hydrogel
microstructures has not yet been shown. Yet, the utilization of scale-relevant interactions
to drive minimizations of interfacial free energy (necessitating shape- and size-controlled
microstructures) should not be incompatible with microstructures derived from standard
tissue engineering hydrogels.
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Figure 5.2: Non-ridged self-assembly. Hydrophilic microstructures of opposite charges
(chitosan and hyaluronic acid) are placed into a hydrophobic mineral oil bath. Charge and
hydrophobic / hydrophilic interactions facilitate self-assembly.
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A similar self-assembly strategy that adopts cell compatible processing conditions may
be extended to commonly used biocompatible hydrogels (poly(ethylene glycol),
hyaluronic acid, alginate, chitosan, fibrin, polylysine, etc.). Any number of scale-relevant
forces could be harnessed to drive self-assembly but initial experiments might utilize a
combination of hydrophobic/hydrophilic and electrostatic interactions. Shape
complementarities between fitting components would allow for these interactions to
increase the specificity of self-assembly. In our initial experiments it may be valuable to
apply this approach to the fabrication of cardiac tissues to enable facile validation (i.e.
known and specific protein expression profiles, distinct phenotypes, etc.) of the approach
although bottom-up tissue engineering is by no means an organ- or tissue-specific
strategy.
5.1 Overview
To form three-dimensional (3D) tissues from cell-laden microstructures, we will develop
approaches to self-assemble shape- and size-controlled components into directed and
reproducible 3D configurations. Our initial experiments will focus on using a
combination of hydrophobic/hydrophilic interactions and electrostatic interactions
between differing hydrogel materials to induce self-assembly. Two useful model
hydrogels may be hyaluronic acid and chitosan: both materials are largely hydrophilic but
hyaluronic acid methacrylate hydrogels are negatively charged while chitosan hydrogels
are positively charged. When placed in a chemically inert and non-toxic hydrophobic
liquid such as mineral oil, these hydrogels should tend to aggregate to reduce interfacial
free energy (Figure 5.2). Proper combinatorial mixing of positively charged chitosan and
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negatively charged hyaluronic acid microstructures with shapes and sizes allowing for
complementary coupling should increase the specificity of self-assembly. In order to
reduce the number of potential slip planes, it is hypothesized that ridge-shaped surfaces
(Figure 5.3) may facilitate superior self-orientation of microstructures during self-
assembly.
5.2 General Experimental Design
Shape-Fitting Self-Assembly: A set of experiments using rectangular polyhedral
microstructures with flat surfaces as well as a parallel set with ridged surfaces will be
performed to assess the importance of precise shape-fitting to self-assembly. We
anticipate the experiments involving ridged components to yield a relative reduction in
the number of structural defects by reducing the number of potential slip planes (from 6
per component to 2). In either case, carefully controlled numbers of methacrylated
hyaluronic acid (MeHA) and chitosan microstructures will be mixed together within a
mineral oil solution (Figure 5.2) with MeHA prepolymer and photoinitiator (prepolymer
and photoinitiator are hydrophilic and form around microstructures) and gently agitated
to induce self-assembly. The assembled 3D macrostructures will then be exposed to UV
light to covalently bond the microstructures to one another, removed from the mineral oil
bath, and washed with PBS. Microscopy will be performed to assess the efficacy of self-
assembly. Particular attention will be paid to the orientation of microstructures within the
larger 3D structure and the number of defectively assembled components will be
quantified and characterized.
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Figure 5.3: Ridged self-assembly. Ridge-shaped hydrophilic microstructures of opposite
charge (chitosan and hyaluronic acid) are placed into a hydrophobic mineral oil bath. The
complementary shape-fitting of opposing ridges are expected to act in unison with
hydrophobic / hydrophilic interactions to further facilitate self-assembly.
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Various parameters will be explored to minimize defects, such as the concentrations of
the microstructures within the aqueous phase, size and shape of the microstructures, the
ratio of the hydrophobic to hydrophilic components and the prepolymer and
photoinitiator concentrations. Initial experiments will involve cell-free microstructures in
order to characterize parameters; subsequent experiments will involve cell-loaded
microstructures as required. If successful, these experiments would represent the first
demonstration of the efficacy of electrostatic interactions in mesoscale self-assembly and
demonstrate that processing conditions for bottom-up engineering can be sufficiently
mild so as to facilitate high cell viability.
Characterization of Self-Assembled Constructs: As a model system for analyzing the
proposed efficacy of bottom-up tissue engineering in enhancing tissue structure and
function, cardiac myofibrils will be encapsulated within microstructures and self-
assembled. We believe that this model tissue if successfully assembled would represent a
powerful demonstration of bottom-up tissue engineering since cardiac function
(contraction) requires alignment of myofibrils and the formation of load-transferring cell-
cell junctions. Cell viability within thin samples of constructs will be analyzed with live-
dead staining and MTT under fluorescence microscopy at reasonable (-daily) intervals
for up to 60 days in culture. The viability of the cells within larger structures may be
examined using confocal microscopy. We will also perform histological analysis on the
resulting macrostructures at each of the above time points to visualize and capture
remodeling characteristics such as the expression of intracellular myosin heavy chain
(and other standard cardiac markers) and N-cadherins at fascia adherens junctions.
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Bottom-up tissue engineering is premised on the hypothesis that different cell types when
appropriately pre-configured within 3D environments would exhibit improved
remodeling over cells randomly seeded within porous scaffolds. This set of analyses will
represent a first step in testing that hypothesis. If indeed bottom-up engineered cardiac
tissues exhibit improved ex vivo morphology and functionality, further in vivo work may
follow.
5.3 Conclusions
Tissue engineering is an intriguing and promising regenerative technology with the
potential to improve the quality of life for millions of individuals. Bottom-up tissue
engineering constitutes a unique alternative to traditional tissue engineering strategies and
when coupled with existing methodologies (physical stimuli and biochemical factors)
may prove to be tremendously useful for producing many forms of complexity, including
built-in vasculature. In this body of work two strategies for producing shape- and size-
controlled microstructures for bottom-up tissue engineering were developed. This final
chapter lays out concrete plans for bridging these microstructures with the concept of
mesoscale self-assembly. The mastery of self-assembling phenomena may someday
enable the recapitulation of all 3D structures within a tissue, from capillaries to veins,
ducts to sinuses, glomeruli to glands.
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